Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms.
OBJECTIVE
To optimise the indication and time for operation for abdominal aortic aneurysm (AAA), we analysed whether or not serum-elastin-peptides (SEP) could be a potential predictor for expansion.


METHODS
Four thousand, four hundred and four 65-73-year-old males were invited for screening to detect an AAA. Three thousand, three hundred and thirty-four attended (76%). One hundred and forty-one had AAA, and 19 > 5 cm in diameter were referred for immediate operation. The remaining 122 AAA were offered an annual follow-up. Ninety-nine were later asked for a blood-sample, 83 attended. SEP was determined using an ELISA-technique. The observer was blinded to the SEP result.


RESULTS
The average expansion was 2.6 mm/year, and 10 (8.1) were referred for operation because of a diameter of > 5 cm. SEP were positively correlated to expansion (R = 0.4, F = 14.65). In multiple regression analyses, AAA size, SEP, beta-agonist-treatment, and FEV1, but not beta-blockers, were predictors of expansion. SEP remained a relatively strong predictor (F = 13.13).


CONCLUSIONS
Serum-elastin-peptides seem to predict expansion, but a larger, longer study is needed to establish clinical recommendations.
Lindholt
J S
JS
Department of Vascular Surgery, Viborg Hospital, Denmark.
Heickendorff
L
L
Henneberg
E W
EW
Fasting
H
H
D000368:Aged; D017544:Aortic Aneurysm, Abdominal / Q000097:blood* / Q000150:complications / Q000473:pathology; D004549:Elastin / Q000097:blood*; D006801:Humans; D016014:Linear Models; D008297:Male; D010455:Peptides / Q000097:blood; D011237:Predictive Value of Tests; D012720:Severity of Illness Index
D010455:Peptides; D004549:Elastin